RE:Rubber hits the roadI think that valuation is certainly possible, but unlikely in the next 2-3 years. Even if we partner on a deal it may dilute the share count and R+D spending isnt likely to slow down anytime soon. Also, revenues would increase but how long would it take to ramp up $100-150 Million in sales/year? In 2-3 years I'd be happy with $1 - 1.75 per share.
On a 5 year target if they can hit on PGX and cholesterol pill than it gets interesting.
For now though I'll be happy if this can break $0.50 lol